Scientific Advisory Board
The Scientific Advisory Board (SAB) of CurePSP, advises the Board of Directors on scientific and medical matters, assists with the educational and research activities of the organization, and reviews research grant applications/proposals on a semi-annual basis. Voting members of the Scientific Advisory Board are prominent scientists and clinicians with expertise pertinent to PSP and CBD genetics, pathology, pathophysiology, clinical manifestations, and management.
Lawrence I. Golbe, MD (Chair)
Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey
Kristophe Diaz, PhD (Ex Officio)
Executive Director and Chief Science Officers, CurePSP
Edward A. Burton, MD, DPhil, FRCP
University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
Ted M. Dawson, MD
Johns Hopkins University School of Medicine, Baltimore, Maryland
Dennis W. Dickson, MD
Mayo Clinic, Jacksonville, Florida
Jason Gestwicki, PhD
University of California, San Francisco, San Francisco, California
Günter U. Höglinger, MD
German Center for Neurodegenerative Diseases & Technical University Munich, Munich, Germany
Virginia M.-Y. Lee, PhD
Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania
Irene Litvan, MD
University of California, San Diego, San Diego, California
Huw R. Morris, PhD, FRCP
National Hospital for Neurology and Neurosurgery and UCL Institute of Neurology, London, England
Bess Frost, PhD
The University of Texas Health Science Center at San Antonio
Gerard D. Schellenberg, PhD
University of Pennsylvania, School of Medicine, Philadelphia, Pennsylvania
Celeste Karch, PhD
Washington University School of Medicine, St. Louis, MO
Gabor Kovacs, MD, PhD
University of Toronto, Toronto, Ontario